Clinical Trial Update: Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder [Phase 3]

View source ↗

Summary

Open-label extension study of methylphenidate hydrochloride extended-release in adults with ADHD; results from a Phase 3 trial have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Attention Deficit/Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-05-26